ArticleDigestive diseases and sciences2020

Low Rate of Drug Discontinuation, Frequent Need for Dose Adjustment, and No Association with Development of New Arthralgia in Patients Treated with Vedolizumab: Results from a Tertiary Referral IBD Center.

Jason Reinglas et al.PubMed ↗Publisher ↗

No numbers read from the abstract.